Ling-Ling Li

Pathogenesis, epidemiology and control of Group A Streptococcus infection

FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI/ML-based approaches

Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions

A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin